Edwards Lifesciences Corporation provided earnings guidance for the second quarter of 2024. For the quarter, the company projects total sales to be between $1.62 billion and $1.70 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
87.98 USD | +0.59% | -2.00% | +15.38% |
May. 23 | Some of the biggest splits in Corporate America | RE |
May. 22 | Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.38% | 53.02B | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.28% | 65.19B | |
+3.64% | 50.28B | |
+8.37% | 44.15B | |
+3.27% | 36.45B | |
+23.97% | 31.33B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences Corporation Provides Earnings Guidance for the Second Quarter of 2024